| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/09/2004 | CN1152675C IL-8 receptor antagonists |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747061 N-substituted dithiocarbamates for the treatment of biological disorders |
| 06/08/2004 | US6747054 EP4 receptor selective agonists in the treatment of osteoporosis |
| 06/08/2004 | US6747053 Heteroaryl nitriles |
| 06/08/2004 | US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 06/08/2004 | US6747039 Aza-benzothiopyranoindazoles with antitumor activity |
| 06/08/2004 | US6747035 Antiinflammatory agents; antiallergens |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | US6747026 NK-1 receptor active amine oxide prodrugs |
| 06/08/2004 | US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals |
| 06/08/2004 | US6747016 Substituted purine derivatives as inhibitors of cell adhesion |
| 06/08/2004 | US6747013 Such as rheumatoid arthritis; gene therapy, such as to replace a defective apoptotic gene, to cells in the affected area |
| 06/08/2004 | US6747002 Determination, calibration erythropoietin dosage; analyzing using computer |
| 06/08/2004 | US6746673 For prophylaxis and/or treatment of an autoimmune disease or rheumatoid arthritis |
| 06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |
| 06/03/2004 | WO2004046199A2 Novel method of obtaining chondroitin sulphuric acid and uses thereof |
| 06/03/2004 | WO2004046152A1 Diazinopyrimidines |
| 06/03/2004 | WO2004045627A1 A3ar agonists for the treatment of inflammatory arthritis |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2003102183A9 Pramyxovirus vectors encoding antibody and utilization thereof |
| 06/03/2004 | WO2003092595A3 Tyrosine kinase inhibitors |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 06/03/2004 | WO2003048153A8 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 06/03/2004 | WO2003016567A3 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106675 class of compounds generally called the "statins" for use in stimulating bone formation and method to identify compounds useful in this regard by assessing their ability to inhibit enzymes in the pathway of isoprenoid synthesis |
| 06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106654 Inhibitors of copper-containing amine oxidases |
| 06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 06/03/2004 | US20040106632 5-(4-{2-'(6-methoxy-pyrimidin-4-yl)methyl-amino)-ethoxy}-benzyl)-thiazolidin-2,4-dione sodium salt |
| 06/03/2004 | US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same |
| 06/03/2004 | US20040106615 For treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant |
| 06/03/2004 | US20040106610 Antagonize pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106595 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 06/03/2004 | US20040106558 Hydroxamate-containing cysteine and serine protease inhibitors |
| 06/03/2004 | US20040106550 comprises chondromodulin-1 protein which grows articular chondrocytes by itself or under coexistence with fibroblast growth factor, and is capable of suppressing hyper degradation of cartilage matrix; gene therapy |
| 06/03/2004 | US20040106538 Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance |
| 06/03/2004 | US20040106196 Systems and methods for treating patients with processed lipoaspirate cells |
| 06/03/2004 | US20040106134 Comprises genetically engineered immunoglobulin for use in the treatment of bone disorders |
| 06/03/2004 | CA2506565A1 Diazinopyrimidines |
| 06/02/2004 | EP1424336A1 1,3-benzothiazinone derivatives and use thereof |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424330A1 Activator for peroxisome proliferator-responsive receptor delta |
| 06/02/2004 | EP1424326A1 Fused-polycyclic compounds |
| 06/02/2004 | EP1424082A1 Method of regenerating bone/chondral tissues by transferring transcriptional factor gene |
| 06/02/2004 | EP1424080A1 Gnrh agonist combination drugs |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423436A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 06/02/2004 | EP1423432A2 Interleukin-1 beta antibodies |
| 06/02/2004 | EP1423428A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423412A2 Homing peptides |
| 06/02/2004 | EP1423406A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 06/02/2004 | EP1423391A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423386A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 06/02/2004 | EP1423380A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423378A1 Aminopyrrole compounds as antiinflammatory agents |
| 06/02/2004 | EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors |
| 06/02/2004 | EP1423364A1 Crystalline forms of 'r-(r*,r*)!-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 06/02/2004 | EP1423356A2 Novel aminobenzoephenones |
| 06/02/2004 | EP1423143A2 Crystal forms and mutants of rank ligand |
| 06/02/2004 | EP1423140A2 Compositions and methods for modulation of immune responses |
| 06/02/2004 | EP1423132A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 06/02/2004 | EP1423121A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 06/02/2004 | EP1423082A2 Plasma protein matrices and methods for their preparation |
| 06/02/2004 | EP1423081A2 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 06/02/2004 | EP1423080A2 Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors |
| 06/02/2004 | EP1423012A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 06/02/2004 | EP1244614B1 Tryptase inhibitors |
| 06/02/2004 | EP1227824B1 Transplant/implant device and method for its production |
| 06/02/2004 | EP1171113B1 Compounds useful as phosphotyrosine mimics |
| 06/02/2004 | CN1501940A Composition and method for inhibiting platelet aggregation |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501909A Novel succinate salt of o-desmethyl-venlafaxine |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501803A Use of 2alpha-methyl-19-nor-20(s)-1alpha, 25-dihydroxyvitamin d3 to increase bone strength |
| 06/02/2004 | CN1501799A Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
| 06/02/2004 | CN1501798A Medicinal compositions comprising diclofenac and ornoprostil |
| 06/02/2004 | CN1500876A Full length polynucleotide order of coding fowl ó� type collagen and uses thereof |
| 06/02/2004 | CN1500810A Fibroblast growth factor-2 analogue, producing process and application thereof |
| 06/02/2004 | CN1500809A Fibroblast growth factor-2 analogue, producing process and application thereof |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500523A Protein preparation for enhancing sclerotin and its preparation method |
| 06/02/2004 | CN1500502A Medicine for adjusting qi and killing pain |
| 06/02/2004 | CN1152048C Perfluoroalkyl ketone inhibitors of elastase and preparing method thereof |
| 06/02/2004 | CN1152011C Vitamin D analogues and pharmaceutical uses thereof |
| 06/02/2004 | CN1151838C Use of proteins as agents against autoimmune diseases |
| 06/02/2004 | CN1151831C Decoction of external use for curing lupus erythematosus |